£111.84

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£112 today · all-time low £111 (Sep 2026) · usually £112

Humana Animal Models of Neurological Disease, II: Metabolic Encephalopathies and Epilepsies: 22 (Neuromethods, 22)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£120.61 £110.51 £112.72 £114.92 £117.12 £119.32 £121.53 25 July 2026 09 August 2026 24 August 2026 08 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 3 price levels

Days at Price
Current Price
19 days · current 4 days 39 days 0 10 20 29 39 £112 £119 £121 Days at Price

Price Analysis

Most common price: £121 (39 days, 62.9%)

Price range: £112 - £121

Price levels: 3 different prices over 62 days

Description

to the Animal Models Volumes This and several other volumes in the Neuromethods series will describe a number of animal models of neuropsychiatric disorders. Because of increasing public concern over the ethical treatment of animals in research, we felt it incumbent upon us to include this general preface to these volumes in order to indicate why we think further - search using animals is necessary and why animal models of psychiatric disorders, in particular, are so important. We recognize that animals should only be used when suitable alternatives are not available. We think it self-e- dent, however, that humans can only be experimented upon in severely proscribed circumstances and alternative pro- dures using cell or tissue culture are inadequate in any models requiring assessments of behavioral change or of complex in vivo processes. However, when the distress, discomfort, or pain to the animals outweighs the anticipated gains for human welfare, then the research is not ethical and should not be carried out. It is imperative that each individual researcher examine his/her own research from a critical moral standpoint - fore engaging in it, taking into consideration the animals’ welfare as well as the anticipated gains. Furthermore, once a decision to proceed with research is made, it is the researcher’s responsibility to ensure that the animals’ w- fare is of prime concern in terms of appropriate housing, feeding, and maximum reduction of any uncomfortable or distressing effects of the experimental conditions, and that these conditions undergo frequent formalized monitoring.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care
97% match

Psychiatric Aspects Of Neurologic Diseases: Practical Approaches to Patient Care

Oxford University Press

£24.54 02 Oct 2026
Handbook of Neurochemistry: Volume VII Pathological Chemistry of the Nervous System
96% match

Handbook of Neurochemistry: Volume VII Pathological Chemistry of the Nervous System

Springer

£84.26 02 Oct 2026
SPEC – Handbook of Clinical Neurology, Volume 144, Huntington Disease, 12-Month Access, eBook (Volume 144)
96% match

SPEC – Handbook of Clinical Neurology, Volume 144, Huntington Disease, 12-Month Access, eBook (Volume 144)

Elsevier

£172.86 06 Sep 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03
96% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03

Springer

£107.85 23 Sep 2026
Molecular and Functional Models in Neuropsychiatry: 7 (Current Topics in Behavioral Neurosciences, 7)
96% match

Molecular and Functional Models in Neuropsychiatry: 7 (Current Topics in Behavioral Neurosciences, 7)

Springer

£146.28 27 Sep 2026
Psyche, Schmerz, sexuelle Dysfunktion
96% match

Psyche, Schmerz, sexuelle Dysfunktion

Springer

£63.08 21 Sep 2026
Psychiatric Controversies in Epilepsy
96% match

Psychiatric Controversies in Epilepsy

Elsevier

£65.99 23 Sep 2026
Art and Neurological Disorders: Illuminating the Intersection of Creativity and the Changing Brain (Current Clinical Neurology)
96% match

Art and Neurological Disorders: Illuminating the Intersection of Creativity and the Changing Brain (Current Clinical Neurology)

Humana

£47.12 24 Sep 2026
Art and Neurological Disorders: Illuminating the Intersection of Creativity and the Changing Brain (Current Clinical Neurology)
96% match

Art and Neurological Disorders: Illuminating the Intersection of Creativity and the Changing Brain (Current Clinical Neurology)

Humana

£65.61 05 Sep 2026
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
96% match

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Springer

£104.34 24 Sep 2026
Concise Guide to Neuropsychiatry and Behavioral Neurology (Concise Guides)
96% match

Concise Guide to Neuropsychiatry and Behavioral Neurology (Concise Guides)

American Psychiatric Association Publishing

£47.54 23 Sep 2026
Secondary Influences on Neuropsychological Test Performance (National Academy of Neuropsychology: Series on Evidence-Based Practices)
96% match

Secondary Influences on Neuropsychological Test Performance (National Academy of Neuropsychology: Series on Evidence-Based Practices)

Oxford University Press

£160.00 26 Sep 2026
Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment
96% match

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Springer

£114.88 02 Oct 2026
Neuropsychology, Neuropsychiatry, and Behavioral Neurology (Critical Issues in Neuropsychology)
96% match

Neuropsychology, Neuropsychiatry, and Behavioral Neurology (Critical Issues in Neuropsychology)

Springer

£146.85 24 Sep 2026
Essentials of Clinical Neurology for The Psychiatrist
96% match

Essentials of Clinical Neurology for The Psychiatrist

Jaypee Brothers Medical Publishers

£53.69 11 Sep 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
96% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£104.34 17 Sep 2026
In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)
96% match

In Vivo Neuropharmacology and Neurophysiology: 121 (Neuromethods, 121)

Humana

£81.06 26 Sep 2026
Neuropsychiatric Symptoms of Epilepsy (Neuropsychiatric Symptoms of Neurological Disease)
96% match

Neuropsychiatric Symptoms of Epilepsy (Neuropsychiatric Symptoms of Neurological Disease)

Springer

£86.71 24 Sep 2026
Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)
96% match

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Humana

£149.42 27 Sep 2026
Injury Models of the Central Nervous System: Methods and Protocols: 1462 (Methods in Molecular Biology, 1462)
96% match

Injury Models of the Central Nervous System: Methods and Protocols: 1462 (Methods in Molecular Biology, 1462)

Humana

£81.74 30 Sep 2026
Machine Learning for Brain Disorders: 197 (Neuromethods, 197)
96% match

Machine Learning for Brain Disorders: 197 (Neuromethods, 197)

Humana

£40.79 02 Oct 2026